title: [Pneumococcal vaccine].
abstract: Streptococcus pneumoniae is a common cause of morbidity and mortality in children, immunodeficient individuals and elderly people. As antibiotic resistant strains become more prevalent, pneumococcal infections will become more difficult to manage. Pneumococcal vaccination is inexpensive, and serious side effects are rare. However, the efficacy and safety of the vaccine have been questioned, and the use of vaccination is limited. This article discusses factors to be considered when assessing the indications for pneumococcal vaccination. Immunisation together with a strict policy on the use of antibiotics are our most efficient means for preventing pneumococcal disease and spread of antibiotic resistant strains. Norwegian physicians are encouraged to use pneumococcal vaccine according to the present indications.
authors.affiliation: Medisinsk avdeling, Haukeland Sykehus, Bergen.
authors.forename: R W
authors.initials: RW
authors.lastname: Flø
authors.forename: C O
authors.initials: CO
authors.lastname: Solberg
mesh_terms: D001428:Bacterial Vaccines / Q000008:administration & dosage* / Q000191:economics; D006801:Humans; D011008:Pneumococcal Infections / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic; D012189:Retrospective Studies
chemical_list: D001428:Bacterial Vaccines
vernacular_title: Pneumokokkvaksinen.